• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B. BRAUN MEDICAL INC. ESPOCAN®; SPINAL EPIDURAL ANESTHESIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B. BRAUN MEDICAL INC. ESPOCAN®; SPINAL EPIDURAL ANESTHESIA Back to Search Results
Model Number 333196
Medical Device Problem Code Break (1069)
Health Effect - Clinical Codes Needle Stick/Puncture (2462); Foreign Body In Patient (2687)
Type of Reportable Event Malfunction
Event or Problem Description
As reported by the user facility: the patient gave informed consent for combined spinal epidural (cse) anesthesia and was brought to an operating room.The patient assumed a sitting position, and an anesthesiology resident, who was approximately halfway through their ca1 year (resident in first year of clinical anesthesiology training), performed local infiltration with approximately 3 ml of lidocaine 1% at the midline of the l5/s1 interspace using a 27-gauge needle that was 3.2 cm in length attached to a 3-ml luer lock syringe.The cse kit used was an eposcan combined spinal and epidural anesthesia tray manufactured by b.Braun medical.A cse technique was then attempted at this interspace, and insertion of the 12.7-cm pencan 25-gauge spinal needle through the tuohy needle did not produce backflow of cerebrospinal fluid.Rather than administer anesthesia in the epidural space, the plan was to reattempt a cse at a different lumbar interspace.The anesthesiology resident provided local infiltration at the l4/l5 interspace with an additional 3 ml of lidocaine 1% with the same 27-gauge needle.In conducting this local anesthetic infiltration, the resident inserted the needle superior to the interspace, partially withdrew the needle, and then inserted the needle inferior to the interspace.After complete withdrawal of the needle, it was noted that the needle had fractured from its hub and that a needle fragment was presumably retained in the subcutaneous tissue.The patient and attending obstetrician were immediately informed of this complication, but the patient denied any pain from the needle fragment at this time.The attending obstetrician spent approximately 10 minutes exploring the subcutaneous tissue with a scalpel and forceps attempting to remove the needle fragment while a general surgeon was consulted via telephone and advised that the patient could safely assume the supine position and that retrieval of the needle fragment could be deferred until after completion of the cesarean delivery.The attending anesthesiologist then successfully performed a cse anesthetic at the l5/s1 interspace, the patient was laid supine, and the cesarean delivery was performed without further incident.The patient was brought to the interventional radiology suite to attempt removal of the needle fragment.The patient was positioned prone and moderate sedation was achieved with intravenous fentanyl 150 [?]g and midazolam 8 mg given in divided doses.The patient had received hydromorphone 4 mg in an oral tablet approximately 5 hours before the procedure for incisional pain as the intrathecal morphine had been administered >24 hours earlier.Using fluoroscopy, the needle was visualized at the l4/l5 interspace.
 
Additional Manufacturer Narrative
This report has been identified as b.Braun medical internal report number (b)(4).No sample and/or lot number were provided.Further investigation of the complaint is not possible without a sample and/or lot number.The actual defective device is valuable tool in investigating the cause of this incident.We will maintain this report for further references and continue to monitor other reports for similar occurrences.If any additional pertinent information becomes available, a follow up will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESPOCAN®
Common Device Name
SPINAL EPIDURAL ANESTHESIA
Manufacturer (Section D)
B. BRAUN MEDICAL INC.
901 marcon blvd.
allentown PA 18109
Manufacturer Contact
jonathan severino
901 marcon blvd.
allentown, PA 18109
4847197287
MDR Report Key14427196
Report Number2523676-2022-00193
Device Sequence Number17749466
Product Code OFT
UDI-Device Identifier04046964179303
UDI-Public(01)04046964179303
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number333196
Device Catalogue Number333196
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/04/2022
Initial Report FDA Received Date05/18/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age29 YR
Patient SexFemale
Patient Weight123 KG
-
-